Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China flag China · Delayed Price · Currency is CNY
19.90
+0.03 (0.15%)
May 29, 2026, 3:00 PM CST

SHA:600645 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,5841,0101,5281,5811,3931,196
Trading Asset Securities
150.61712.05----
Cash & Short-Term Investments
1,7351,7221,5281,5811,3931,196
Cash Growth
11.82%12.72%-3.38%13.48%16.54%12.76%
Accounts Receivable
607.26628.36644.94610.53575.98510.95
Other Receivables
13.43.271.9918.0928.4116.58
Receivables
620.66631.63646.93628.62604.39527.53
Inventory
231.68230.23232.19247.9248.09226.96
Prepaid Expenses
-00.512.386.482.98
Other Current Assets
74.5672.9248.8948.3657.6477.08
Total Current Assets
2,6622,6572,4562,5082,3102,030
Property, Plant & Equipment
603.52613.97688.71705.33765.54766.09
Long-Term Investments
726.43732.72736.84779.96804.31886.53
Goodwill
702.91702.91702.91702.91702.91702.91
Other Intangible Assets
120.884.7100.45101.42111.73133.96
Long-Term Accounts Receivable
17.5119.2828.4737.455265.9
Long-Term Deferred Tax Assets
49.4450.4692.9581.856.0246.94
Long-Term Deferred Charges
120.52166.6165.22159.98148.88141.13
Other Long-Term Assets
262.16264.68277.08334333.2259.72
Total Assets
5,2655,2925,2495,4115,2855,033
Accounts Payable
96.7738.5547.3268.7656.8532.12
Accrued Expenses
43.05166.56170.15146.96134.91132.33
Current Portion of Long-Term Debt
---6.316.316.31
Current Portion of Leases
21.4821.3943.7523.3421.1916.69
Current Income Taxes Payable
32.1510.546.7117.9330.3824.97
Current Unearned Revenue
1,1321,1331,1341,1371,1121,078
Other Current Liabilities
88.0687.9685.481.29109.64105.56
Total Current Liabilities
1,4131,4581,4871,4821,4711,396
Long-Term Debt
---9.4615.7722.08
Long-Term Leases
52.8358.888088.3797.937.11
Long-Term Unearned Revenue
9.9810.089.5610.0210.9211.08
Long-Term Deferred Tax Liabilities
10.0610.5512.9523.1534.8734.7
Other Long-Term Liabilities
11.6-----
Total Liabilities
1,4981,5371,5901,6131,6311,501
Common Stock
467.95467.95467.95467.95467.95467.95
Additional Paid-In Capital
3,3893,3893,3743,3773,3843,383
Retained Earnings
-55.85-80.09-193.92-294.27-400.73-513.71
Treasury Stock
-200.03-200.03-200.03---
Comprehensive Income & Other
118.14129.8147.54133.31104.7125.98
Total Common Equity
3,7193,7073,5953,6843,5563,463
Minority Interest
48.1548.2463.98114.5597.8569.31
Shareholders' Equity
3,7673,7553,6593,7993,6543,533
Total Liabilities & Equity
5,2655,2925,2495,4115,2855,033
Total Debt
74.3280.27123.75127.48141.1882.2
Net Cash (Debt)
1,6611,6421,4041,4541,2521,113
Net Cash Growth
15.97%16.94%-3.42%16.09%12.46%11.14%
Net Cash Per Share
3.613.613.083.142.662.37
Filing Date Shares Outstanding
455.9455.9455.9467.95467.95467.95
Total Common Shares Outstanding
455.9455.9455.9467.95467.95467.95
Working Capital
1,2481,199968.931,027838.53634.56
Book Value Per Share
8.168.137.897.877.607.40
Tangible Book Value
2,8952,9192,7922,8802,7412,627
Tangible Book Value Per Share
6.356.406.126.155.865.61
Land
-3.463.543.493.433.14
Buildings
-546.03546.68482.6497.7558.38
Machinery
-696.34700.82690.88653.02623.86
Construction In Progress
-5.6510.5418.9823.2320.5